Skip to content

pn_blog-post_alert-logo_hubspot

PN_email_Headers_Alert-Banner

Long-Term Lecanemab Leads to Less Cognitive Decline, Better Quality of Life

12/10/25 12:15 PM

Long-term treatment (up to 36 months) with lecanemab continued to produce benefits for patients with...

This is a search field with an auto-suggest feature attached.

There are no suggestions because the search field is empty.

Subscribe Here!

cover_december_2025

News From Current Issue

Special Report: Communicating the Neurobiology of MDD
Why Narcolepsy Is Often Missed—and How to Spot It
Integrating Psychiatric Pharmacists Into Practice

Read This Week's Update

PN_email_Headers_Update-Banner

The content of Psychiatric News does not necessarily reflect the views of APA or the editors. Unless so stated, neither Psychiatric News nor APA guarantees, warrants, or endorses information or advertising in this newspaper. Clinical opinions are not peer reviewed and thus should be independently verified.